News 2024
6th shipment on its way: The FZB supports partner university in Ukraine with medicines and technical aids
Since February 24, 2022, Ukraine has been under attack by the army of the Russian Federation. The war has brought suffering and misery to parts of this country in our European neighborhood. Millions of Ukrainians have left their homes as a result of the war. According to conservative figures from the UNHCR, more than 10,000 civilians and between 30,000 and 70,000 soldiers (there are no reliable official figures) from Ukraine have so far fallen victim to the Russian war of aggression.
Congratulations! Borstel Scientist Receives DGHM Advancement Award 2024
Prof. Dr. Caroline Barisch has been honoured for her scientific work investigating and analysing the virulence strategies employed by the bacterium Mycobacterium tuberculosis to create optimal conditions for its intracellular replication.
LCI Summer School on "Molecular Infectious Diseases Epidemiology"
Doctoral students from the Bernhard Nocht Institute for Tropical Medicine (BNITM), the Research Center Borstel, Leibniz Lung Center (FZB) and the Leibniz Institute of Virology (LIV) met for a three-day meeting on "Molecular Infectious Diseases Epidemiology". The three institutes organized the summer school as part of the Leibniz Center Infection (LCI) Graduate School as a joint event with the Hamburg Leibniz ScienceCampus "Integrative Analysis of Pathogen-induced Compartments" (InterACt). The summer school offered the doctoral students plenty of time for dialogue and networking.
Prevention of tuberculosis: When should contact persons receive preventive treatment?
In a large-scale systematic review, researchers from an international consortium examined more than 25,000 publications from the last 20 years. They examined under which circumstances contact persons of tuberculosis (TB) sufferers benefit from receiving preventive antibiotic therapy so that they do not fall ill themselves. The results showed that the effective strategy depends on the TB incidence of the country: in low-incidence countries, it makes sense to give preventive treatment only to contact persons who have been tested with a skin test or blood test indicating contact with tuberculosis bacteria. In high-incidence countries, all close contacts of people with tuberculosis should receive preventive treatment if no tests are available.